D.E. Shaw & Co
OCDX

D.E. Shaw & Co’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

D.E. Shaw & Co’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,338
Closed -$342K – 6019
2022
Q1 		$342K Sell
18,338
-89,879
-83% -$1.62M ﹤0.01% 4586
2021
Q4 		$2.31M Sell
108,217
-97,688
-47% -$1.92M ﹤0.01% 3220
2021
Q3 		$3.81M Buy
205,905
+188,755
+1,101% +$3.8M ﹤0.01% 2383
2021
Q2 		$367K Buy
+17,150
New +$349K ﹤0.01% 4177

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

D.E. Shaw & Co's OCDX Position: Q2 2022 in Review

D.E. Shaw & Co sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 18,338 shares — an estimated $342K sold.

D.E. Shaw & Co first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $3.81M in Q3 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • D.E. Shaw & Co reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 18,338 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $342K.
  • D.E. Shaw & Co first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
  • D.E. Shaw & Co's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $3.81M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.